Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

Buzz on the Bullboards: Tracking Bombardier’s path, Tilray’s growth

This year began on a confusing path for investors as sectors struggle under greater inflation costs and hopes of an imminent interest rate cut fade. A few weeks later in 2024, we are starting to see a clearer picture of where many companies are headed this year. M...
Jonathon Brown | January 18, 2024 |

Buzz on the Bullboards: More tricks than treats in today’s stock market?

It has been an uneasy week for markets on Bay Street and Wall Street. After the TSX hit a two-week low a few days ago, the Bank of Canada voted to keep interest rates at 5 per cent, kicking off a risk rally. U.S. markets have also fared well as optimism grows that...
Jonathon Brown | October 26, 2023 |

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon | September 27, 2023 |

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

Buzz on the Bullboards: AI stocks and energy plays getting noticed

Markets have had it rough, starting the month of August lower following one downer of a corporate earnings report after another. Wall Street has struggled since credit assessor Fitch downgraded the United States’ credit rating from gold-standard AAA to...
Jonathon Brown | August 3, 2023 |

Delivering innovative remote patient monitoring

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Cloud DX is emerging as the partner of choice among the largest global medical technology companies to provide innovative, best-in-class remote patient monitoring (RPM) solu...
Brieanna McCutcheon | September 22, 2022 |

Buzz on the Bullboards: Feeling the tech selloff?

It has been a turbulent week on Bay Street and Wall Street. Canada’s commodity-heavy main stock index tumbled this week, weighed down by a near 5% drop in crude prices on demand concerns, while bullion prices slipped to a four-week low further hurting...
Stockhouse Editorial | April 27, 2022 |

Buzz on the Bullboards: A Bigger Picture for Smaller Caps

(Image via Blackberry Ltd.) The business of war weighs on the minds of investors and companies today. It is not just that, but the push to re-emerge from the COVID-19 pandemic to supply chain issues, business has been adapting. Take BlackBerry Limited ( TSX: BB...
Stockhouse Editorial | March 23, 2022 |

Remote Patient Monitoring: A Recurring Revenue Business Model that’s Moving Markets

Just about a year ago , we introduced our Stockhouse investor audience to a soon-to-be publicly listed company that was revolutionizing the digital and virtual healthcare space. Fast-forward to today and Cloud DX Inc. ( TSX-V.CDX , OTC: CDXFF , Forum ) is now publicly tr...
Dave Jackson | March 17, 2022 |
1 2 3 4 5 6 7 8 9 10